CN Patent

CN115844838B — 一种可注射的药物组合物

Assigned to Zhejiang Cuize Pharmaceutical Technology Co ltd · Expires 2023-10-24 · 3y expired

What this patent protects

本发明公开一种可注射的药物组合物及其制备方法与应用。所述药物组合物包含活性成分和药学上可接受的辅料；所述活性成分包含卡博特韦或其药学上可接受的盐，所述辅料包含表面活性剂、助悬剂。本发明提供的药物组合物及其制剂用于HIV感染的治疗和预防，稳定性好，适合工业化生产。

USPTO Abstract

本发明公开一种可注射的药物组合物及其制备方法与应用。所述药物组合物包含活性成分和药学上可接受的辅料；所述活性成分包含卡博特韦或其药学上可接受的盐，所述辅料包含表面活性剂、助悬剂。本发明提供的药物组合物及其制剂用于HIV感染的治疗和预防，稳定性好，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN115844838B
Jurisdiction
CN
Classification
—
Expires
2023-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Cuize Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.